UMIN-CTR Clinical Trial

Basic information
Official scientific title of the study	A survey on microcirculation (711)
Title of the study (Brief title)	A survey on microcirculation (711)
Region	Japan

Condition
Condition	Healthy adults
Classification by specialty	Cardiology Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	Analysis the relationship between microcirculation and state of extremities.
Basic objectives2	Others
Basic objectives -Others	Analysis the relationship between microcirculation and state of extremities.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	-Objective indicators as microcirculation of extremities and so on. -Subjective indicators as questionnaire.
Key secondary outcomes

Base
Study type	Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	59 years-old >=
Gender	Male
Key inclusion criteria	-Healthy male
Key exclusion criteria	-Subjects who have been suffered from a critical disease -Subjects who take prescription medicine -Subjects with the illness of a vascular function -Subjects with atopic dermatitis, eczema and pollen allergy -Subjects with smoking habit -Subjects who are in poor physical condition -Subjects who have an abnormality of measurement skin site -Subjects undergoing trauma in the measurement site -Subjects who are influenced by the adhesive -Subjects who participate in the other examinations which have an influence on this examination -Subjects deemed inappropriate to participate in this study by the principle investigator
Target sample size	50

Research contact person
Name of lead principal investigator	Takatoshi Murase
Organization	Kao Corporation
Division name	R&D -Core Technology- Biological Science Research
Address	2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, JAPAN
TEL	0285-68-7871
Email	murase.takatoshi@kao.co.jp

Public contact
Name of contact person	Daiji Kagawa
Organization	Kao Corporation
Division name	R&D -Core Technology- Biological Science Research
Address	2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, JAPAN
TEL	0285-68-7458
Homepage URL
Email	kagawa.daiji@kao.co.jp

Sponsor
Institute	Kao Corporation
Institute
Department

Funding Source
Organization	Kao Corporation
Organization
Division
Category of Funding Organization	Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funｄer(s)

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions	花王株式会社栃木事業場（栃木県）

Other administrative information
Date of disclosure of the study information	2016 Year 08 Month 26 Day

Progress
Recruitment status	Completed
Date of protocol fixation	2016 Year 08 Month 09 Day
Anticipated trial start date	2016 Year 08 Month 29 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results	Unpublished
URL releasing results
Results
Other related information	Subjects are recruited with the result of pre-questionnaire and without the key exclusion criteria

Management information
Registered date	2016 Year 08 Month 23 Day
Last modified on	2016 Year 10 Month 27 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027303